XML 43 R33.htm IDEA: XBRL DOCUMENT v3.6.0.2
Revenue Recognition (Details Textual) - USD ($)
3 Months Ended 6 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Jun. 30, 2016
Revenue Recognition [Line Items]          
Revenue, Net, Total $ 794,000 $ 448,000 $ 1,492,000 $ 914,000  
Deferred Revenue         $ 426,000
License and Maintenance Revenue 0 $ 21,000 0 $ 43,000  
KOREA, REPUBLIC OF | Korean Pharmaceutical Company [Member]          
Revenue Recognition [Line Items]          
Deferred Revenue 500,000   $ 500,000    
Deferred Revenue Recognition Period     10 years    
CANADA | Canadian Based Supplier [Member]          
Revenue Recognition [Line Items]          
Deferred Revenue $ 250,000   $ 250,000    
Deferred Revenue Recognition Period     7 years